🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted steps to tackle cost of living challenges" in next month's Budget.

During an interview with media outlets, she emphasized that curbing price rises is a joint responsibility of both the administration and the central bank.

The UK's price growth is expected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Possible Utility Cost Interventions

Sources suggest the administration could take action to bring down energy bills, for instance by cutting the current 5% level of value-added tax applied on energy supplies.

An additional option is to reduce some of the government charges presently included in household expenses.

Budgetary Limitations and Expert Expectations

The administration will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for these measures.

The expectation from the majority of experts is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to meet her self-imposed debt limits.

Previously on Thursday, estimates suggested there was a £22 billion deficit for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a shared responsibility between the Bank of England and the administration to further reduce some of the drivers of inflation," the Chancellor informed the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and International Issues

While much of the focus has been on probable tax increases, the Treasury chief said the latest information from the OBR had not altered her pledge to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with growing geopolitical and commercial concerns for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

International Economic Disputes

Referring to concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always take priority."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other materials that are crucial for advanced tech production led American leader Donald Trump to suggest an additional 100% import tax on imports from China, raising the prospect of an all-out trade war between the two economic giants.

The American finance chief called China's move "commercial pressure" and "a global supply chain power grab."

Questioned on accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese measures and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "harmful for the international commerce and generates additional headwinds."

"In my view there are sectors where we must confront China, but there are also significant opportunities to sell into China's economy, including banking sector and other areas of the economic system. We've got to maintain that balance correct."

The Treasury chief also confirmed she was cooperating with international partners "on our own essential resources approach, so that we are less reliant."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the cost the NHS pays for drugs could increase as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the biggest global drug companies have said lately that they are either pausing or scrapping operations in the United Kingdom, with some attributing the low prices they are getting.

Last month, the Science Minister said the cost the health service spends on drugs would need to go up to prevent businesses and drug research funding departing from the UK.

Reeves stated to media: "We have seen as a result of the cost structure, that clinical trials, innovative medicines have not been offered in the UK in the manner that they are in other continental states."

"We want to ensure that patients receiving care from the National Health Service are able to receive the best critical treatments in the world. And so we are looking at this situation, and... aiming to secure increased investment into Britain."